The Valley Desk

Clinical trial reportNature medicinePublished

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature medicine
Published
Subject terms
CD8-Positive T-Lymphocytes; Humans; Glioblastoma; Brain Neoplasms; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Antigens, CD; Adult; Aged; Middle Aged; Female; Male
PubMed ID
42432293
PubMed Central ID
PMC13375532
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal